Zentalis Pharmaceuticals (ZNTL) Intangibles (2019 - 2021)

Zentalis Pharmaceuticals' Intangibles history runs 3 years deep, the most recent figure standing at $8.8 million for Q2 2021.

• In Q2 2021, Intangibles changed 0.0% year-over-year to $8.8 million; the TTM figure through Jun 2021 stood at $8.8 million (changed 0.0% YoY), while the FY2020 annual figure was $8.8 million, changed 0.0% from the prior year.
• Intangibles was $8.8 million for Q2 2021 at Zentalis Pharmaceuticals, roughly flat from $8.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $8.8 million in Q4 2019 to a low of $8.8 million in Q4 2019.
• Historically, Intangibles has averaged $8.8 million across 3 years, with a median of $8.8 million in 2019.
• Biggest YoY gain for Intangibles was 0.0% in 2020; the steepest drop was 0.0% in 2020.
• A 3-year view of Intangibles shows it stood at $8.8 million in 2019, then changed by 0.0% to $8.8 million in 2020, then changed by 0.0% to $8.8 million in 2021.
• The last three Intangibles figures came in at $8.8 million (Q2 2021), $8.8 million (Q1 2021), and $8.8 million (Q4 2020), per Business Quant data.